Last reviewed · How we verify
Adamgammadex Sodium — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Adamgammadex Sodium (Adamgammadex Sodium) — Amckaus PTY LTD..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Adamgammadex Sodium TARGET | Adamgammadex Sodium | Amckaus PTY LTD. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Adamgammadex Sodium CI watch — RSS
- Adamgammadex Sodium CI watch — Atom
- Adamgammadex Sodium CI watch — JSON
- Adamgammadex Sodium alone — RSS
Cite this brief
Drug Landscape (2026). Adamgammadex Sodium — Competitive Intelligence Brief. https://druglandscape.com/ci/adamgammadex-sodium. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab